Evidence map›Paper›PMID 32409140›Full record

ReviewAcademic radiology2021

The Role of Imaging in Health Screening: Overview, Rationale of Screening, and Screening Economics.

David H Ballard, Kirsteen R Burton, Nikita Lakomkin, Shannon Kim, Prabhakar Rajiah, Midhir J Patel, Parisa Mazaheri, Gary J Whitman

Open access · greenAbstract readReview
In one paragraph

Review in Academic radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

David H BallardMallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd, Campus Box 8131, St. Louis, MO 63110. Electronic address: davidballard@wustl.edu.
Kirsteen R BurtonInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario.
Nikita LakomkinIcahn School of Medicine at Mount Sinai, New York, New York.
Shannon KimDepartment of Radiology, Eastern Virginia Medical School Norfolk, Virginia.
Prabhakar RajiahDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Midhir J PatelAdventHealth Medical Group Radiology - Central Florida Division, Orlando, Florida.
Parisa MazaheriMallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd, Campus Box 8131, St. Louis, MO 63110.
Gary J WhitmanDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mallinckrodt (United States) · USEastern Virginia Medical School · USFlorida Hospital Medical Group · USIcahn School of Medicine at Mount Sinai · USMayo Clinic · USThe University of Texas MD Anderson Cancer Center · USUniversity of Toronto · CA

Funding

Training OPportunities in Translational Imaging Education and Research (TOP-TIER)T32EB021955 · NIBIB · WASHINGTON UNIVERSITY · PI Hongyu An, Joseph Edward Ippolito · 2017 to 2026
$2.4M
NIBIB NIH HHS T32 EB021955
6 · The paper itself

Abstract

Imaging screening examinations are growing in their indications and volume to identify conditions at an early, treatable stage. The Radiology Research Alliance's 'Role of Imaging in Health Screening' Task Force provides a review of imaging-based screening rationale, economics, and describes established guidelines by various organizations. Various imaging modalities can be employed in screening, and are often chosen based on the specific pathology and patient characteristics. Prevalent disease processes with identifiable progression patterns that benefit from early potentially curative interventions are ideal for screening. Two such examples include colonic precancerous polyp progression to adenocarcinoma in colon cancer formation and atypical ductal hyperplasia progression to ductal carcinoma in situ and invasive ductal carcinoma in breast cancer. Economic factors in imaging-based screening are reviewed, including in the context of value-based reimbursements. Global differences in screening are outlined, along with the role of various organizational guidelines, including the American Cancer Society, the US Preventive Services Task Force, and the American College of Radiology.

Indexed as

AdenocarcinomaBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingAdvisory CommitteesDiagnostic ImagingHumansMass ScreeningUnited StatesHealthcare economicsImaging screeningLead time biasLength time biasPopulation screeningRadiology screeningScreening economics

Identifiers

PMID32409140
PMCPMC7655697
OpenAlexW3025338242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.